ArticleMolecular oncology2016

miR-634 exhibits anti-tumor activities toward hepatocellular carcinoma via Rab1A and DHX33.

Chris Zhiyi Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.